Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
30
# OF OVERLAPPING
HOLDINGS
BMED
133
HOLDINGS
29%
ALSO IN WDNA
WDNA
85
HOLDINGS
36%
ALSO IN BMED
SECTOR DRIFT (BMED minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.6% | 1.9% | 1.9% |
|
ALNYLAM PHARMACEUTICALS INC | 1.8% | 3.0% | 1.8% |
|
NATERA INC | 1.8% | 4.4% | 1.8% |
|
DANAHER CORP | 1.3% | 1.3% | 1.3% |
|
BLUEPRINT MEDICINES CORP. | 1.2% | 3.8% | 1.2% |
BMED Overweight Relative to WDNA
|
BOSTON SCIENTIFIC CORP | 5.3% |
|
INTUITIVE SURGICAL INC | 4.4% |
 |
ROCHE HOLDING AG-BR | 3.4% |
|
ABBVIE INC | 3.1% |
|
LONZA GROUP AG-REG | 3.1% |
 |
ARGENX SE ADR | 3.0% |
|
UCB SA | 2.6% |
|
ABBOTT LABORATORIES | 2.6% |
 |
MEDTRONIC PLC | 2.3% |
|
INSULET CORP | 2.3% |
BMED Underweight Relative to WDNA
 |
NOVOZYMES A/S-B SHARES | -3.2% |
|
BRIDGEBIO PHARMA, INC. | -3.1% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
NATERA INC | -2.6% |
|
ELI LILLY & CO | -2.3% |
|
AGIOS PHARMACEUTICALS INC | -2.1% |
|
VERACYTE INC | -2.1% |
|
TWIST BIOSCIENCE CORP. | -2.0% |
|
NOVARTIS AG | -1.9% |
|
VERICEL CORPORATION | -1.8% |